Literature DB >> 12065569

Evaluating neoadjuvant chemotherapy in breast cancer.

Gilbert Lawrence, John Crawford, Faina Sherman.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12065569     DOI: 10.1200/JCO.2002.20.12.2905

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.

Authors:  J Xue; Y Chi; Y Chen; S Huang; X Ye; J Niu; W Wang; L M Pfeffer; Z-M Shao; Z-H Wu; J Wu
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

2.  MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.

Authors:  Min-Min Liu; Zhi Li; Xue-Dong Han; Jian-Hua Shi; Dao-Yuan Tu; Wei Song; Jian Zhang; Xiao-Lan Qiu; Yi Ren; Lin-Lin Zhen
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.